Asker Healthcare Group AB (publ) ASKER.ST
Nasdaq Stockholm · Healthcare · Medical Distribution
76.10 SEK
+0.7%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for Asker Healthcare Group
| SEK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 11,718 | 13,453 | 15,025 | 16,787 |
| EBITDA | 1,116 | 1,120 | 1,469 | 1,686 |
| Net income | 430 | 203 | 360 | 492 |
| Balance sheet | ||||
| Equity | 2,763 | 3,023 | 3,469 | 6,555 |
| Total debt | 4,741 | 4,973 | 5,957 | 5,814 |
| Cash | 211 | 391 | 490 | 884 |
| Net debt | 4,530 | 4,582 | 5,467 | 4,930 |
| Ratios and per share | ||||
| EBITDA margin | 9.5% | 8.3% | 9.8% | 10.0% |
| Profit margin | 3.7% | 1.5% | 2.4% | 2.9% |
| Return on equity | 15.6% | 6.7% | 10.4% | 7.5% |
| Earnings/share (SEK) | 1.12 | 0.53 | 0.94 | 1.28 |
| Book value/share (SEK) | 7.21 | 7.89 | 9.06 | 17.11 |
| Shares outstanding (M) | 383 | 383 | 383 | 383 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 59.2 |
| P/B | 4.4 |
| EV / EBITDA | 20.2 |
| Net debt / EBITDA | 2.9 |
| Return on equity | 7.5% |
| Profit margin | 2.9% |
| Beta 1Y | 0.81 |
| Revenue growth 1Y | +11.7% |
| Revenue CAGR 3Y | +12.7% |
| Earnings/share CAGR 3Y | +4.6% |
| ROE avg. 3Y | 8.2% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (SEK)
| 2026 | 0.39 |
Not investment advice. Figures may contain errors from the data source.